COMPEX TECHNOLOGIES INC
MANUFACTURING AGREEMENT
<DOCUMENT>
<TYPE>EX-10.17
<SEQUENCE>2
<FILENAME>c98425exv10w17.htm
<DESCRIPTION>MANUFACTURING AGREEMENT
<TEXT>
<HTML>
<HEAD>
<TITLE>exv10w17</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: Helvetica,Arial,sans-serif">


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>Exhibit&nbsp;10.17</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>OEM AGREEMENT</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>THIS AGREEMENT </B>is made as of the 24th day of May, 2005, by and between <B>Compex Technologies,
Inc. (&#147;Compex&#148;), </B>a Minnesota Corporation at 1811 Old Highway Eight, New Brighton, Minnesota, 55112,
and <B>Bionicare Medical Technologies, Inc. (&#147;Bionicare&#148;) </B>located at 47R Loveton Circle, Sparks,
Maryland, 21152.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>WHEREAS</B>, Compex and Bionicare are parties to that certain OEM Agreement dated as of February
28, 2002 (the &#147;Original Agreement&#148;);
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>WHEREAS</B>, pursuant to the Original Agreement Bionicare provided to Compex a copy of Bionicare&#146;s
patented wavelength technology and a schematic for an output circuit (collectively, the &#147;Bionicare
Technology&#148;) for a electrical stimulation device for clinical applications in regeneration of
cartilage of the knee;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>WHEREAS</B>, Compex incorporated the Bionicare Technology into its proprietary design for a hand
held electrical stimulation device which includes Compex&#146;s microprocessor, controls, patented open
lead detection systems, software controls relating to wave amplitude, user compliance software and
other features (the &#147;Compex Technology&#148;) in order to create a more compact version of the product;
and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>WHEREAS</B>, pursuant to the original agreement, Compex manufactured and supplied to Bionicare,
for purchase, marketing, distribution and resale by Bionicare, the Products listed on the attached
Exhibit&nbsp;A (including the lead wire, battery and battery charger packaged and shipped therewith,
hereinafter referred to as the &#147;Products&#148;), incorporating the Bionicare Technology and the Compex
Technology;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>WHEREAS</B>, the Original Agreement expired on March&nbsp;20, 2004, and Compex and Bionicare desire to
renew the terms under which they operated in the Original Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In consideration of the foregoing, and for other good and valuable consideration, the receipt
and adequacy of which is hereby acknowledged, the parties agree as follows:
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left"><B>1.</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U><B>Term</B></U>. Subject to early termination in accordance with Section&nbsp;10, this Agreement is
effective upon execution (the &#147;Effective Date&#148;) and for an initial period ending June&nbsp;30, 2008
(the &#147;Initial Term&#148;), but shall be automatically renewed for successive one (1)&nbsp;year terms (a
&#147;Renewal Term&#148;) after the Initial Term unless either party provides notice to the other party
of its intent to cancel at least 180&nbsp;days prior to expiration of the Initial Term or any
renewal term. Each one year period commencing on July 1 and ending June&nbsp;30 during the Term of
this Agreement is herafter referred to as a &#147;Contract Year.&#148;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left"><B>2.</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U><B>Manufacture</B></U>. Compex agrees to use its commercially reasonable efforts to manufacture
the Products and to sell the Products to Bionicare, and Bionicare shall use Compex as its sole
and exclusive manufacturer and source of supply for the Products, during the term of and in
accordance with the provisions of this Agreement. Compex acknowledges that the Products will
be manufactured with unique serial numbers and that it will maintain detailed production
records for seven (7)&nbsp;years. Subject to changes required to comply with QSR requirements,
Compex will not change the specifications for the Products without Bionicare&#146;s prior written
consent. Bionicare shall pay all nonrecurring engineering charges associated any change
requested by Bionicare in Product specifications at the nominal labor rate for engineers of
sixty dollars ($60) per hour and the nominal labor rate for technicians of thirty dollars
($30) plus actual cost of required tooling.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left"><B>3.</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U><B>Purchase Orders and Delivery Schedule</B></U></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">a)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Within 30&nbsp;days of the Effective Date, Bionicare shall issue a purchase order to
Compex covering the total product requirements for Contract Year commencing July&nbsp;1,
2005. Such purchase order shall contain (i)&nbsp;the type and quantity of the Products
ordered, including</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt">1
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: Helvetica,Arial,sans-serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">


<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>whether such Product is to be in &#147;Kitted&#148; form or not in &#147;Kitted&#148; form, (ii)&nbsp;the
requested delivery date for such Products by each month in such Contract Year (the &#147;PO
Delivery Schedule&#148;), (iii)&nbsp;the requested location for delivery, (iv)&nbsp;the requested
method of delivery, and (v)&nbsp;such other information as may reasonably be required by
Compex. Any other terms in Bionicare&#146;s purchase order are considered void and deleted.
Bionicare shall deliver an additional, revised Purchase Order covering each Contract
Year during the term of this Agreement by April 1 next preceding such Contract Year,
each of which shall contain a PO Delivery Schedule with respect to such Contract Year.
Each Purchase Order shall be subject to review and acceptance by Compex and shall, once
accepted, be binding as set forth herein. Each Purchase Order shall be binding and
non-cancelable with respect to the first three months of Product set forth in the PO
Delivery Schedule.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">b)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>By the 15<SUP style="font-size: 85%; vertical-align: text-top">th</SUP> day of each month, commencing with July&nbsp;15, 2005,
Bionicare shall provide to Compex a revised delivery schedule (a &#147;Revised Delivery
Schedule&#148; and together with the PO Delivery Schedule, a &#147;Delivery Schedule&#148;) with
respect to the four calendar months commencing with the first day of the first month
after such Delivery Schedule is due. Such Revised Delivery Schedule shall be binding
on, and noncancellable by, Bionicare with respect to the first three months of Product
scheduled for Delivery as set forth therein. To the extent that such Revised Delivery
Schedule sets forth increased scheduled delivery for Product during the first month
covered thereby (the &#147;Overlap Month&#148;), Compex will use its reasonable commercial
efforts to satisfy such scheduled deliveries, but shall not be obligated to deliver
more Product with respect to such Overlap Month than was scheduled in the next
preceding Delivery Schedule.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">c)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Bionicare shall not be entitled to reschedule the delivery of any Product for
which the Purchase Order has become binding, including specifically the first three
months of deliveries under the PO Delivery Schedule, and the first three months of
deliveries under any revised Delivery Schedule. To the extent Compex shall ship
Product in accordance with such Delivery Schedule, Bionicare shall be fully liable for
payment in accordance with Section&nbsp;6. No requested delivery delay on any order
previously accepted by Compex will be effective unless acknowledged in writing by
Compex. Compex shall have the right to cancel any order placed or delay shipment
thereof if Bionicare fails to make payment due Compex, or if actions or omissions on
the part of Bionicare caused a delay in Compex&#146; performance.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">d)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Bionicare acknowledges that the Products incorporate Compex Technology and that
Compex has and will devote considerable resources to integrating the Products with the
Bionicare Technology. Accordingly, Bionicare agrees that Bionicare will purchase its
entire supply of Products, and any replacement products, from Compex. For such
purposes, &#147;replacement products&#148; means any product that replaces a Product that has
been discontinued, or that provides effectively the same functions as a Product and
which substantially diminishes sale of the Product after introduction.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>4. </B><U><B>Pricing</B></U>
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">a)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The prices for the Products initially shall be as set forth in Exhibit&nbsp;A for
the quantities specified in each Purchase Order, provided, however, that if at any time
during a Contract Year, Bionicare (i)&nbsp;submits a Delivery Schedule that causes the
scheduled deliveries of Product to total, on a cumulative basis from the first day of
such Contract year, less than the cumulative scheduled deliveries set forth in the PO
Delivery Schedule through that date in the Contract Year, or (ii)&nbsp;Bionicare fails to
timely pay any invoice in accordance with Section&nbsp;6, then the prices for all Product
delivered from the beginning of such Contract Year shall be the price set forth in
Exhibit&nbsp;A assuming the Purchase Order related to the smallest quantity of Product set
forth in Exhibit&nbsp;A, and Bionicare shall immediately pay to Compex the difference
between the purchase price actually paid for Product invoiced during such Contact Year,
and the product of such revised purchase price and all such Product invoiced. For the
avoidance of doubt, if either of the events set forth in (i)&nbsp;or (ii)&nbsp;above occur, the
price of the Products shall change</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt">2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: Helvetica,Arial,sans-serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">


<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>retroactively for all Product shipped during the Contract Year. All prices are stated
and shall be paid in United States Dollars. Compex may increase the price of the
Products annually during the Initial Term, and prior to any Renewal Term, on 60&nbsp;days
notice to Bionicare, but only to the extent its cost of manufacture of the Products has
increased. Any such notice shall be accompanied by information sufficient for Bionicare
to determine the reasons for such increase in cost of manufacture.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">b.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Unless otherwise agreed to in writing by Compex, all prices are quoted
exclusive of transportation and insurance costs, and all taxes, duties and assessments
(except taxes levied against Compex&#146; income) including state and local use, sales,
property and similar taxes. Bionicare agrees to pay such taxes, unless Bionicare has
provided Compex with (i)&nbsp;an exemption resale certificate in the appropriate form for
the jurisdiction of Bionicare&#146;s place of business and any jurisdiction to which Product
is to be directly shipped, or (ii)&nbsp;written evidence that such sale is otherwise exempt
from such taxes. In the event Compex is required to pay any tax or transportation
charges, Bionicare shall reimburse Compex. When applicable, such transportation and
taxes shall appear as separate items on Compex&#146; invoice.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left"><B>5.</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U><B>Shipments</B></U></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(a)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><I>Method</I>. All shipments will be made F.O.B. Compex&#146; plant. Delivery will be
deemed complete and risk of loss or damage to the Products will pass to Bionicare upon
delivery to the carrier, the carrier acting exclusively as Bionicare&#146;s agent. The
carrier will be selected by Compex in the absence of specific instructions by
Bionicare. In no event shall Compex be liable for any delay in delivery, or assume any
liability in connection with shipment. All claims for damages must be filed with the
carrier. Unless otherwise agreed in writing, all Products will be packaged, packed and
shipped in accordance with Compex&#146; normal practices.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(b)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><I>Delivery</I>. All shipping dates are estimates only. Shipments may be made in
installments. Compex shall be excused from performance, in whole or in part, caused by
the occurrence of any contingency beyond Compex&#146; reasonable control, including but not
limited to, war, judicial action, labor dispute, accident, default of suppliers, fire,
act of God, shortage of labor fuel, raw material or machinery or technical or yield
failures, where Compex has exercised commercially diligent efforts in the prevention
thereof.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left"><B>6.</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U><B>Terms of Payment</B></U></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">a.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><I>Separate Transactions</I>. Compex shall invoice each shipment separately as of the
date of shipment and shipment shall constitute a separate and individual contract. All
invoices are due and payable thirty (30)&nbsp;days from date of invoice. Any invoice not
paid within thirty (30)&nbsp;days from the date of invoice shall bear interest at the lesser
of one and one-half percent (1.5%) per month or the highest rate permissible under
applicable law.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">b.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><I>Approval</I>. Shipments, deliveries, and performance of work shall at all times be
subject to the approval of Compex&#146; credit department and Compex may at any time decline
to make any shipments or deliveries or perform any work except upon receipt of payment,
or upon terms and conditions or security satisfactory to Compex. If shipments are
delayed by Bionicare, payment shall become due, at Compex&#146; option, thirty (30)&nbsp;days
after the date Compex is prepared to make shipment. Compex reserves the right to
establish and/or change credit and payment terms extended to Bionicare when, in Compex&#146;
sole opinion, Bionicare&#146;s financial condition or previous payment record warrants such
action.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">c.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><I>Security Interest</I>. Bionicare hereby grants and Compex retains a purchase money
security interest in each Product furnished under any purchase order accepted under
this Agreement, and any proceeds thereof, until the full purchase price thereof has
been paid in full. Bionicare agrees that Compex may perfect such security interest and
that Bionicare will promptly execute any documents necessary to perfect such security
interest, upon Compex&#146; request.</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt">3
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: Helvetica,Arial,sans-serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">


<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">d.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><I>Inspection</I>. Unless otherwise specified and agreed in writing, the Products
shall be subject to Bionicare&#146;s standard inspection at the place of manufacture. If by
mutual agreement Bionicare is to inspect at the place of manufacture, such inspection
shall be conducted so as not unreasonably to interfere with Compex&#146; operations, and
Bionicare&#146;s conclusive approval or rejection shall be made before shipment.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">e.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><I>Acceptance</I>. Bionicare may, at Bionicare&#146;s sole option and expense, conduct
incoming inspection and acceptance tests. The Product shall be deemed accepted by
Bionicare unless Compex receives written notice of defect as to any Product within
thirty (30)&nbsp;days of shipment. In the event the Products appear not to conform,
Bionicare shall immediately notify Compex and afford Compex a reasonable opportunity to
inspect the material at Bionicare&#146;s plant. No Products shall be returned without
Compex&#146; prior written consent.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left"><B>7.</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U><B>Confidentiality/ Ownership of Intellectual Property</B></U><B>.</B></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">a)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Compex hereby acknowledges that the Bionicare Technology is the sole and
exclusive property of Bionicare and Bionicare acknowledges that the Compex Technology
is the sole and exclusive property of Compex. Bionicare hereby provides to Compex a
nonexclusive license during the term of this Agreement to manufacture for sale to
Bionicare, the Products using the Bionicare Technology. Compex hereby provides to
Bionicare during the term of this Agreement, a nonexclusive license under the Compex
Technology to distribute, market and resell the Products.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">b)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Any invention or trade secret hereafter developed by Bionicare or its personnel
shall be the sole and exclusive property of Bionicare. Bionicare will pay all expenses
relating to the securing and maintaining of appropriate intellectual property
protection with respect to such inventions<B>. </B>Any invention or trade secret hereafter
developed by Compex or its personnel shall be the sole and exclusive property of
Compex. Compex will pay all expenses relating to the securing and maintaining of
appropriate intellectual property protection with respect to such inventions<B>.</B></TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">c)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>In the event that personnel of Compex and Bionicare jointly participate in an
invention or trade secret, such invention or trade secret, and the intellectual
property related thereto shall be owned jointly by the Parties. Determination of
inventorship shall be made in accordance with U.S. patent laws. The Parties shall
jointly share in the expenses of obtaining intellectual property protection of any
joint invention.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">d)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Each party to this Agreement acknowledges and agrees that they have, prior to
the date of this Agreement, and will, after the Effective Time, disclose to the other
party confidential and trade secret information relating to product design, software
code and other matters (collectively, &#147;Confidential Information&#148;). Each Party shall
take the same reasonable measures as it uses to protect its own confidential
information from the unauthorized disclosure or misuse to protect the other Party&#146;s
Confidential Information from unauthorized disclosure or misuse, including without
limitation, any disclosure by its employees, agents, contractors, permitted
sublicensees, or consultants of the other Party&#146;s Confidential Information. As used
herein, the term reasonable measures shall mean at least those measures a Party applies
to the protection of its own Confidential Information and the term misuse shall mean
use for any purpose other than as permitted or required hereunder. The terms of this
Agreement itself shall be deemed to be Confidential Information. In the event that a
Party is required to disclose the content of this Agreement pursuant SEC requirements
or requirements of any securities exchange on which a Party&#146;s share are listed and
traded, such Party shall use its reasonable efforts to obtain confidential treatment of
at least the following portions of the Agreement: (i)&nbsp;financial terms (such as all
dollar amounts and price terms), (ii)&nbsp;quantities and (iii)&nbsp;time periods.</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt">4
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: Helvetica,Arial,sans-serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">


<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">e)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Notwithstanding any other provision in this Section&nbsp;7, Bionicare and Compex
jointly acknowledge that they both function in the market for the use of electrical
stimulation for medical therapy or rehabilitation and that nothing in this Agreement
shall create any presumption that any development of Bionicare has been made or is
based on the Compex Technology or that any development of Compex has been made or is
based on the Bionicare Technology.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left"><B>8.</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U><B>Warranty, Repair And Indemnification</B></U></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">a)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><I>Generally</I>. THIS WARRANTY IS IN LIEU OF ALL OTHER WARRANTIES, EXPRESSED,
STATUTORY, OR IMPLIED, INCLUDING THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS
FOR A PARTICULAR PURPOSE, AND OF ALL OTHER OBLIGATIONS OR LIABILITIES ON COMPEX&#146;S PART.
THIS WARRANTY IS FOR THE SOLE BENEFIT OF BIONICARE, AND NEITHER ASSUMES NOR AUTHORIZES
ANY OTHER PERSON TO ASSUME FOR COMPEX ANY OTHER LIABILITIES IN CONNECTION WITH THE SALE
OF THE PRODUCTS. Compex warrants to Bionicare only that the Products delivered under
this Agreement will be free from defects in material and workmanship under normal use
and service for a period of three (3)&nbsp;years from the date of shipment.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">b)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><I>Limitation</I>. Compex&#146;s entire obligation under this Warranty and Bionicare&#146;s
exclusive remedy is limited, at Compex&#146;s option, to replacing, repairing or giving
credit for, any non-conforming Product. In order to qualify for Warranty protection,
all defective Products must be returned to Compex&#146;s factory of origin, transportation
charges prepaid, and, after examination, be disclosed, to Compex&#146;s sole satisfaction,
to be thus defective and within this Warranty. Bionicare has no authority to extend
this Warranty to any other person or entity. This Warranty shall not apply to any
Products which have been (i)&nbsp;repaired or altered, except by Compex, (ii)&nbsp;subjected to
misuse, negligence, or accident, or (iii)&nbsp;not handled or maintained in conformance with
Compex&#146;s handling, installation or operating instructions.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">c)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><I>Repair</I>. Any work or rework on Products which fall outside the Warranty set
forth above, including repairs and remanufacture or service rental return, shall be
performed in accordance with this subsection (c). During the Term, Compex shall
provide remanufacturing services for Bio1000 devices, but not any accessories or
peripherals, that are delivered to its manufacturing plant in New Brighton, Minnesota.
Such remanufacturing services shall consist of:</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>An electronic test of the Product;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>A visual inspection of the Product;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>A cleaning of the product and , if provided, its carrying case;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Labeling the Product and, if provided, its carrying case with a new serial number;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Recordation of the serial number in Compex&#146;s electronic database.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Such remanufactured product shall be specifically labeled as remanufactured and shall be
re-delivered to Bionicare for the charges set forth in the attached Exhibit&nbsp;B.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Compex shall ship remanufactured Product that it has received and for which it has
performed remanufacturing services in accordance with this subsection (c)&nbsp;to Bionicare
FOB Compex&#146;s manufacturing plan, with invoice at time of shipment for the
remanufacturing costs in accordance with Exhibit&nbsp;B. Compex may, at its election,
include in Product originally shipped to Bionicare a prepaid return mailer for Product
returned for remanufacture, and to the extent a customer has used such prepaid mailer,
Compex shall include the cost of postage for such prepaid mailer in the invoice to
Bionicare and Bionicare shall reimburse Compex for such postage. Bionicare shall pay
for such remanufactured Product in accordance with Section&nbsp;6.</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt">5
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: Helvetica,Arial,sans-serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">


<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Compex warrants remanufactured Product to the same extent as original Product as set
forth in subsections (a)&nbsp;and subject to the limitations contained in subsection (b)&nbsp;of
this Section&nbsp;8 but only until the expiration of three years from the initial shipment
of such Product to Bionicare as a new product (and not the shipment as remanufactured),
or until 90&nbsp;days after shipment as remanufactured product , which ever is greater, and
not for a period of three years after the date of shipment of such remanufactured
Products.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">d)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><I>Indemnification</I>. Bionicare agrees to indemnify, defend and hold harmless
Compex and its officers, directors and employees from and against any and all damages,
liabilities, claims, costs, charges, judgments and expenses (including interest,
penalties and reasonable attorneys&#146; fees) (collectively &#147;Damages&#148;) incurred by such
party that arise out of or result from the design, sale, or use, or misuse of the
Products, excepting only Damages arising directly from a claim of design defect of the
Product that relate to the Product&#146;s microprocessor as it relates to the control of the
specific functions of open lead detection, function key operation, user compliance
software, and liquid crystal display operation and the circuitry related to those
specific microprocessor functions (such excepted Damages, the &#147;Compex Defects&#148; ) .
Compex agrees to indemnify, defend and hold harmless Bionicare and its officers,
directors and employees from and against Damages arising from a claim of design defect
of the Product that is found, by final judgment, to be primarily attributable to the
Compex Defects.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">e)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Each of Compex and Bionicare shall maintain comprehensive product liability
insurance policy with respect to the product in an amount of not less than $3,000,000
per occurrence. Each party shall name the other party as an additional insured under
such policy.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left"><B>9.</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U><B>Regulation</B></U></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">a)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><I>Regulatory Approvals</I>. Bionicare shall be responsible for all regulatory
approvals relating to the distribution, marketing and sale of the Products. Bionicare
represents and warrants to Compex that it currently has all such regulatory approvals,
including, without limitation that it has received letters under Section 510(k) of the
United States Food, Drug and Cosmetics Act indicating that the Products may be marketed
and sold in the United States. Bionicare shall be solely responsible for labeling the
products, all in compliance with Sections 201(k) and 201(m) respectively of the U.S.
Federal Food, Drug and Cosmetics Act.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">b)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><I>Manufacturing</I>. Compex represents that its manufacturing facilities have been
inspected under the FDA&#146;s QSR regulations, and that its manufacturing practices and
facilities currently comply with the QSR regulations and it maintains documents in the
manner required by such regulations with respect to manufacturing, testing and control
activities.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">c)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><I>Recalls</I>. Bionicare shall be responsible for initiating and reporting, and
shall bear all costs and expenses of any recall of any Products and shall reimburse
Compex for the reasonable, out-of-pocket costs incurred by Compex as a result of such
recall, including the replacement cost of any Products affected thereby.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left"><B>10.</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U><B>Termination</B></U></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">a)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>This Agreement may be terminated prior to the expiration of the term set forth
in Section&nbsp;1:</TD>
</TR>

</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 9%">(i)&nbsp;By either party for a material breach of this Agreement that has not been
cured within 30&nbsp;days of notice;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 9%">(ii)&nbsp;By Compex if Bionicare fails to purchase the Products ordered pursuant to
any Purchase Order;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 9%">(iii)&nbsp;To the extent permitted by U.S. bankruptcy law, immediately upon written
notice in the event of the bankruptcy or insolvency of the other Party.
</DIV>

<P align="center" style="font-size: 10pt">6
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: Helvetica,Arial,sans-serif">

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Notwithstanding the foregoing, either Compex or Bionicare may cancel any obligation to
provide remanufacturing services in accordance with Section 8(c) at any time upon 90
days notice; provided that Bionicare shall remain liable to Compex for any product
remanufactured prior to such cancellation and for reimbursement of any postage on
prepaid mailers charged after such cancellation.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">b)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Upon termination or expiration of this Agreement :</TD>
</TR>

</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 9%">(i)&nbsp;the licenses granted in this Agreement will immediately terminate, excepting
only a license to Bionicare to sell Products purchased from Compex prior to such
termination or expiration;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 9%">(ii)&nbsp;Each party will immediately cease use of the other party&#146;s Technology;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 9%">(iii)&nbsp;Bionicare shall purchase, at Compex&#146;s cost, all inventory parts and/or
Product, which is in Compex&#146;s possession or Compex has agreed to purchase,
documented by purchase orders, from suppliers to meet Bionicare&#146;s &#145;delivery
forecast&#146;;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 9%">(iv)&nbsp;each Party&#146;s obligations under Section&nbsp;7, and any unfulfilled obligations
under Section&nbsp;6, shall survive termination or expiration.
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left"><B>11.</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U><B>Relationship of the Parties</B></U></TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The relationship between Compex and Bionicare is that of seller and buyer.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left"><B>12.</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U><B>Governing Law</B></U></TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>This Agreement between Compex and Bionicare is to be governed by, construed and interpreted
in accordance with the laws of the state of Minnesota USA. All claims, cause of action,
lawsuits or other legal proceedings involving this Agreement shall be in a court of
competent jurisdiction or the Sate of Minnesota, USA. Bionicare waives any objection to such
venue.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left"><B>13.</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U><B>Notices</B></U></TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Any notices relating to this Agreement shall be in writing and shall be deemed given when
mailed to the other party at its address set forth above or such other address as such party
shall have designated in writing.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left"><B>14.</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U><B>Assignability</B></U></TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>This Agreement may not be transferred or assigned by Bionicare without the prior written
consent of Compex.</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt">7
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: Helvetica,Arial,sans-serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">



</TABLE>
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date and year first
written above.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Agreed to:</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left"><B>Compex Technologies, Inc.</B></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><B>Bionicare Medical Technologies, Inc.</B></TD>
</TR>
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left"><B>1811 Old Highway 8</B></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><B>47R Loveton Circle</B></TD>
</TR>
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left"><B>New Brighton, MN 55112</B></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><B>Sparks, MD 21152</B></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">By:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="3" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left"><I>Name (type or print)</I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><I>Name (type or print)</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="3" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><I>Title</I>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Title</I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Date:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<P align="center" style="font-size: 10pt">8
</DIV>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
